A series of cosmids covering the majority of the RB1 gene have been isolated from a flow sorted human chromosome 13 specific library. Using fluorescence in situ hybridisation these cosmids were all shown to hybridise to the 13q14 region but not to chromosomes known to carry subband deletions involving the RB1 gene. This panel of cosmids, therefore, can be used objectively for identification of RB1 gene deletions in tumour and normal cells.
The retinoblastoma predisposition gene has been unequivocally assigned' to the 13q14 region by linkage to the esterase D gene (ESD). This localisation had long been suspected23 because of the observation of constitutional 13q14 deletions in some retinoblastoma (Rb) patients. Approximately 3% of Rb patients carry constitutional 13q14 abnormalities. 4 Although the majority of these patients have extensive chromosome deletions, which result in a variety of associated congenital abnormalities, a few carry only subband deletions which could only be detected using high resolution chromosome banding techniques. Although severe mental retardation and dysmorphic features are usually associated with patients with large deletions involving 13ql4,5 which is usually a sufficient indicator of the presence of such a deletion, patients with small, subband deletions may have very few associated phenotypes. We have shown previously that, on occasion, these small deletions may be overlooked using conventional trypsin-Giemsa banding procedures in routine laboratories.6 It is also possible that there are constitutional deletions, as yet undetected, which involve only the RB1 gene or even part of it which cannot be detected cytogenetically. We In the UK, Rb patients are routinely analysed cytogenetically since the presence of a chromosome deletion means that, in the future, prenatal screening of subsequent children is possible in these families. With the development of fluorescence in situ hybridisation (FISH) technology, which shows the presence of DNA sequences directly on metaphase chromosomes, the unequivocal existence of deletions of the RB1 gene can be established. If these deletions are restricted to the RB1 gene they will not be associated with congenital abnormalities which might otherwise identify these patients. Furthermore, since deletions do not affect fertility they can be passed on through the generations. In fact, these deletions will also be missed in screening programmes designed to identify mutations by sequencing9 10 since only the normal allele will be present in constitutional cells. To this end we have isolated and characterised a series of cosmids covering the 5' and 3' ends of the genomic sequence of the RB1 gene which can be used in FISH analysis of chromosomes from Rb patients.
Materials and methods

ANALYSIS OF COSMIDS
Since plasmid sequences would cross react with the cosmid vector in hybridisation experiments using the gridded filter, the 3.8R and 1.8M probes were isolated by electrophoresis and purified using the 'Geneclean' procedure. The gridded filters, provided by the ICRF Genome Analysis Laboratory, were hybridised in Church buffer overnight with the probe radiolabelled by oligonucleotide extension as described by Feinberg and as a unique sequence probe although, when hybridised to total genomic DNA digested with HindIII for example, produces hybridising bands on the autoradiograph which largely correspond to the 3' end of the gene covering exons 18-27. When we screened the gridded chromosome 13 library with 3-8R, seven individual cosmids were identified and recovered. HindIII digests of DNA from these cosmids (fig 1) show that each has restriction fragments in common as well as a few which are unique. When these cosmids were probed with the 3-8R fragment all showed positive hybridisation, although it was clear that only certain bands hybridised in some cosmids compared with others ( fig 2) . From an analysis of the hybridisation pattern it was possible to construct an overlap map of these cosmids which extends into the 3' untranslated region of the gene and into the large (70 kb) intron14 between exons 17 and 18 ( fig 3) . Cosmid H0885 showed an abnormal hybridisation pattern which was not analysed further since the remaining overlapping cosmids proved adequate for the FISH analysis. Curiously, only the exons at the 3' end of the gene were present, possibly because the hybridisation to exons 9-17 is only weak and so were not identified in the primary screen. This is consistent with Southern blot hybridisation experiments where the restriction fragments which hybridise strongly are those encompass- 
.... ing exons 18-27. The absence of exons 9-17 in these cosmids was confirmed using PCR and the oligonucleotides described by Hogg et al." Details of the cosmids from the 3' end of the gene, together with their reference library numbers, are given in table 1. The exons of the RB1 gene cluster in three distinct groups separated by two large introns.'6 We were unable to identify cosmids covering the central part of the gene. The 0.9R fragment covers the first eight exons of RB 1'7 and contains repetitive elements, which makes it difficult to use directly in hybridisation experiments. In order to isolate cosmids from the 5' end of the gene we used a unique sequence DNA probe, Ml.8,18 located in intron 2 of RB1. From this screen five cosmids were isolated all of which were shown to contain exons 1 and 2 using PCR (table 2) and their location within the RB1 gene is shown in fig 3. The seven cosmids from the 3' end of the gene and the five cosmids from the 5' end were used in FISH analysis using metaphase chromosomes from normal persons and they all produced a positive signal exclusively in the q14 region of chromosome 13 ( fig 4) . This strongly suggests that none of these cosmids is chimeric. To determine whether these cosmids could be used to identify chromosome deletions, metaphase chromosomes were prepared from a lymphoblastoid cell line, GOS 115A, derived from the patient discussed by Cowell et al6 with a subband deletion of 13q14. Hybridisation was only observed on one chromosome 13 homologue in each metaphase spread (fig 4) .
During the course of this analysis two patients were referred to us for ESD analysis who carried deletions involving 13ql4. These patients were karyotyped because they showed dysmorphic features and developmental delay. One patient showed del(13)(q12q14.1) the other del (13)(ql4q22). In situ hybridisation showed that only one of the chromosome 13 homologues showed hybridisation with the RB1 cosmids in both cases, confirming that the RB1 gene was included in the deletion. Since this diagnosis the child with the del(13)(ql2qL4.1) has developed tumours but the other patient has not yet, although she is still only 5 months old. We have noted in the past4 that the majority of deletion 13 cases tend to have a later onset of disease than persons carrying the hereditary predisposition owing to point mutations in the RB1 gene. Clearly the del(13)(ql4q22) patient must still be screened ophthalmologically for the forseeable future.
Discussion
The series of cosmids described here can clearly be used to identify Rb patients with constitutional deletions of the RB1 gene. Until now, deletions have traditionally been identified either through cytogenetic G banding analysis, which can be very subjective when small deletions are involved, or by the demonstration that patients have reduced red cell ESD levels.4'9 The ESD gene, which lies proximal to RB 1,20 is at least 200 kb away2l and possibly even further. Thus, deletions of RB1 which do not extend as far as ESD would not be detected by ESD quantitation. Deletions in Rb patients seem to fall into two classes4; those with 13ql2-ql4 deletions and those where the proximal breakpoint lies in 13q14 and the deletion extends distally. From this observation alone it cannot be determined whether RB1 is lost as a result of the deletion. Because these patients usually have mental retardation many of the deletions are identified in the patient before tumours have developed. At this stage the question, therefore, is whether the 13ql2-ql4 deletions extend as far as RB 1 or, when the proximal breakpoint is in 13ql4, is it centromeric to RB1?
The RB1 gene lies on the chromosome with the 5' end towards the centromere.22 Thus, patients presenting with deletions involving proximal parts of the chromosome should be analysed with the M1.8 cosmids and patients with deletions extending distally should be analysed with the 3' cosmids. Failure of any of these cosmids to hybridise means that the patient has lost part, or all, of the RB1 gene and is therefore "at risk" of tumorigenesis and should therefore undergo repeated ophthalmological analysis. Clearly, in routine applications of this technology, representatives from most of the cosmids should be used and a sufficient number of metaphase spreads analysed to confirm that a deletion exists. This type of analysis should supersede ESD quantitation studies which are time consuming to set up especially for small sample numbers, particularly since quality controls must be run before each new set of samples are analysed.'9 The other advantage of FISH analysis over ESD quantification is that it will detect deletions which do not extend to the ESD locus. One such example was reported by Cowell et all3 where the deletion breakpoint lay between ESD and RB1.Y The other advantage of FISH is that the subjectivity associated with metaphase chromosome analysis is removed, particularly when the deletions are small and confined to the 13q14.3 region. In future, therefore, RB1 deletions can be detected by technicians not trained in G banding analysis since, by using the a satellite probe which recognises chromosomes 13 and 21, it is relatively easy to identify the two homologues of chromosome 13 as we have shown. A recent report by Kallionemi et aP4 used 14 phage lambda clones covering RB1 and FISH analysis which could be used to identify RB1 deletions. We feel that cosmids have advantages over phage in that fewer clones are needed to span the gene and it is far simpler to prepare DNA from them. It is unlikely that FISH will detect small intragenic deletions, however, since the cosmids or lambda clones will span the deletion and hybridisation may not be compromised.
The RB 1 gene is also deleted and rearranged in a variety of other tumours including osteosarcoma,8 breast tumours,25 small cell lung cancer,26 and B cell leukaemia. 27 In the latter case particularly, chromosome morphology from tumour cells may not be of sufficient quality to identify small deletions but the panel of cosmids described here will clearly assist in the evaluation of allele loss in those tumours where conventional cytogenetics may have been equivocal.
